Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aase Hensvold

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
European Journal of Immunology|June 10, 2021
Towards prevention of autoimmune diseases: The example of rheumatoid arthritisAase Hensvold, Lars Klareskog
Arthritis & Rheumatology (Hoboken, N.J.)|May 3, 2023
ReplyAkilan Krishnamurthy, Marianne Engström, Aase Hensvold, et al.
Respirology (Carlton, Vic.)|June 28, 2023
Presence of anti-modified protein antibodies in idiopathic pulmonary fibrosisDimitrios Kalafatis, Vijay Joshua, Monika Hansson, et al.
Journal of Translational Autoimmunity|October 6, 2025
Serum test for secretory component-containing anti-citrullinated protein antibodies as a novel prognostic tool in rheumatoid arthritis at-risk subjectsKlara Martinsson, Simon Åhammar, Alexandra Cîrciumaru, et al.
RMD Open|June 11, 2021
Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKLKaterina Chatzidionysiou, Alexandra Circiumaru, Bence Rethi, et al.
Scandinavian Journal of Immunology|May 18, 2026
Novel Biomarker for Rheumatoid Arthritis: Serum Peptidylarginine Deiminase 4-Potentiating Activity in an Anti-Citrullinated Protein Antibody-Positive At-Risk PopulationMarta Kaminska, Vijay Joshua, Ewa Bielecka, et al.
ACR Open Rheumatology|August 8, 2023
Distinct Fluorescence Optical Imaging Patient Clusters Emerge for Seropositive and Seronegative Rheumatoid ArthritisYogan Kisten, Laurent Arnaud, Adrian Levitsky, et al.
Clinical Immunology (Orlando, Fla.)|July 5, 2024
Macrophage activation and inflammatory priming by anti-MAA antibodies in rheumatoid arthritisMarcelo Afonso, Jitong Sun, Koji Sakuraba, et al.
RMD Open|January 31, 2025
<i>Porphyromonas gingivalis</i> associates with the presence of anti-citrullinated protein antibodies, but not with the onset of arthritis: studies in an at-risk populationCharlotte De Vries, Alexandra Cîrciumaru, Linda Mathsson-Alm, et al.
European Journal of Immunology|February 11, 2025
Rheumatoid Arthritis Related B-Cell Changes Are Found Already in the Risk-RA PhaseCharlotte de Vries, Wenqi Huang, Ravi Kumar Sharma, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
European Journal of Immunology|June 10, 2021
Towards prevention of autoimmune diseases: The example of rheumatoid arthritisAase Hensvold, Lars Klareskog
Arthritis & Rheumatology (Hoboken, N.J.)|May 3, 2023
ReplyAkilan Krishnamurthy, Marianne Engström, Aase Hensvold, et al.
Respirology (Carlton, Vic.)|June 28, 2023
Presence of anti-modified protein antibodies in idiopathic pulmonary fibrosisDimitrios Kalafatis, Vijay Joshua, Monika Hansson, et al.
Journal of Translational Autoimmunity|October 6, 2025
Serum test for secretory component-containing anti-citrullinated protein antibodies as a novel prognostic tool in rheumatoid arthritis at-risk subjectsKlara Martinsson, Simon Åhammar, Alexandra Cîrciumaru, et al.
RMD Open|June 11, 2021
Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKLKaterina Chatzidionysiou, Alexandra Circiumaru, Bence Rethi, et al.
Scandinavian Journal of Immunology|May 18, 2026
Novel Biomarker for Rheumatoid Arthritis: Serum Peptidylarginine Deiminase 4-Potentiating Activity in an Anti-Citrullinated Protein Antibody-Positive At-Risk PopulationMarta Kaminska, Vijay Joshua, Ewa Bielecka, et al.
ACR Open Rheumatology|August 8, 2023
Distinct Fluorescence Optical Imaging Patient Clusters Emerge for Seropositive and Seronegative Rheumatoid ArthritisYogan Kisten, Laurent Arnaud, Adrian Levitsky, et al.
Clinical Immunology (Orlando, Fla.)|July 5, 2024
Macrophage activation and inflammatory priming by anti-MAA antibodies in rheumatoid arthritisMarcelo Afonso, Jitong Sun, Koji Sakuraba, et al.
RMD Open|January 31, 2025
<i>Porphyromonas gingivalis</i> associates with the presence of anti-citrullinated protein antibodies, but not with the onset of arthritis: studies in an at-risk populationCharlotte De Vries, Alexandra Cîrciumaru, Linda Mathsson-Alm, et al.
European Journal of Immunology|February 11, 2025
Rheumatoid Arthritis Related B-Cell Changes Are Found Already in the Risk-RA PhaseCharlotte de Vries, Wenqi Huang, Ravi Kumar Sharma, et al.
Pageof 3